3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Classical hematology
1
Conditions
Sarcoma
14
Ovarian Neoplasms
6
Neoplasms
5
Liposarcoma
5
Leiomyosarcoma
5
Liposarcoma, Myxoid
3
Breast Neoplasms
3
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Prostatic Neoplasms
2
Osteosarcoma
2
Neoplasms by Site
2
Neoplasm Metastasis
2
Mesothelioma, Malignant
2
Ichthyosis, X-Linked
2
Endometrial Neoplasms
2
Uterine Neoplasms
1
Solitary Fibrous Tumors
1
Soft Tissue Neoplasms
1
Skin Diseases
1
Sarcoma, Synovial
1
Sarcoma, Endometrial Stromal
1
Sarcoma, Alveolar Soft Part
1
Recurrent High Grade Meningioma
1
Pancreatic Neoplasms
1
Ovarian Diseases
1
Neurofibrosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Mesothelioma
1
Malignant mesenchymal tumor
1
Interventions
olaparib
7
Carboplatin
2
pembrolizumab
1
liposomal doxorubicin
1
iniparib
1
Trabectedin
1
Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Fanconi Anemia, Complementation Group D1
×
Trabectedin
×
Clear all
NCT01772979
2013-01-21
MITO15
Catholic University of the Sacred Heart
Phase 2
Unknown
100 enrolled